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Objective: To assess the validity of the 7th edition of the American Joint Committee on
Cancer TNM staging system for prostate cancer, paying special attention to bladder neck in-
vasion, in an Asian population.
Methods: Clinicopathologic data of 368 men who underwent radical prostatectomy between
2003 and 2011 at our institution were reviewed. The main interest of this study was to confirm
that both isolated positive bladder neck margin and positive bladder neck margin associated
with other surgical margin have more favorable biochemical outcomes than seminal vesicle
invasion (pT3b).
Results: The 3-year biochemical recurrence-free survival for men with organ confined disease,
extraprostatic extension, isolated positive bladder neck margin, positive bladder neck margin
with other surgical margin and seminal vesicle invasion was 88.9, 74.8, 51.2, 19.4 and 18.8%,
respectively. On multivariate analysis, the increased risk of progression associated with an
isolated positive bladder neck margin (hazard ratio 4.34, 95% confidence interval 1.40–13.46,
P ¼ 0.011) was less than that of seminal vesicle invasion (hazard ratio 9.67, 95% confidence
interval 3.70–25.25, P, 0.001). As for the positive bladder neck margin with other surgical
margin, the increased risk of progression (hazard ratio 9.32, 95% confidence interval
3.50–24.82, P, 0.001) was similar to that of men with seminal vesicle invasion.
Conclusions: In our study, men with isolated positive bladder neck margin and positive bladder
neck margin plus other surgical margin had no worse biochemical outcomes than those with
seminal vesicle invasion (pT3b). It is reasonable to classify prostate cancer with bladder neck in-
vasion (the 6th American Joint Committee on Cancer edition pT4 category) into the 7th edition
pT3 category.
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INTRODUCTION
Prostate cancer (Pca) is the most common cancer and the
second leading cause of cancer death in men in the USA and
Europe (1). In Korea, its rate of incidence has increased 20
times over the past two decades (2). Accurate and uniform
staging for a tumor is vital for prediction of its behavior,
treatment selection, evaluation of response to established and
experimental treatments, and exchange of information and
data among institutions. The American Joint Committee on
Cancer (AJCC)/International Union against Cancer (UICC)
tumor, node and metastasis (TNM) staging system is one of
the most commonly used staging systems. The TNM staging
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system for Pca was ﬁrst introduced in 1992 when the AJCC/
UICC adopted a uniﬁed TNM staging system (3). Repeated
revisions (4,5) have been undertaken in an effort to optimize
prognostic accuracy.
The 2010 AJCC staging system (6), the new 7th edition,
made several changes from the 2002 version (6th edition) in
the staging of Pca. These changes included extraprostatic ex-
tension (EPE) and microscopic bladder neck (BN) invasion,
both being included in the T3a category, Gleason score
being recognized as the preferred grading system and the
prognostic factors of Gleason score and preoperative
prostate-speciﬁc antigen (PSA) being incorporated into stage
grouping.
However, there is a paucity of literature investigating the
validity of this change for Asian populations. Here, we
aimed to assess the validity of the 7th edition of the AJCC
TNM system for Pca, paying special attention to positive BN
margin (þBN) (pT3a), in Korean men.
PATIENTS AND METHODS
We reviewed the medical records from a total of 379 patients
who underwent radical prostatectomy (RP) under a diagnosis
of Pca between July 2003 and April 2011 at our institution.
Patients who received preoperative androgen deprivation or
radiation therapy were excluded. Patients who had lymph
node metastasis were excluded because they were at high risk
for recurrence independent of RP specimen pathology. We
also excluded men with unknown overall surgical margin
(SM) status and men with known overall SM status but in
whom the exact anatomical location(s) of the positive
margins were unknown. This resulted in a ﬁnal study popula-
tion of 368 men. Pathological analysis of RP specimens was
performed as previously described by True (7): prostates were
inked along their surface area, and SMs were considered posi-
tive when carcinoma cells were seen to be in contact with the
inked specimen surface. Tumor volume was determined using
a visual estimation: The area of the tumor was measured in x
and y diameters and multiplied by the depth, based on the
presence of tumor in subsequent sections and the thickness of
the sections. The sum total of all foci of tumor was the esti-
mated tumor volume. Biochemical recurrence (BCR) was
deﬁned as a PSA of 0.2 ng/ml or greater after RP.
The main interest of this study was to conﬁrm that þBN
(both isolated þBN and þBN associated with at least one
other þSM) after RP has a more favorable biochemical
outcome than seminal vesicle (SV) invasion (pT3b). To
compare BCR-free survival (BFS) among patients with an
isolated þBN vs organ conﬁned (OC) disease (pT2), EPE
(pT3a), seminal vesicle (SV) involvement (pT3b) and þBN
associated with other SM(s), the Kaplan–Meier method with
the log-rank test was used. The multivariate Cox proportion-
al hazards models predicting BFS were ﬁt with preoperative
PSA, pathological Gleason sum, tumor volume and patho-
logical stage.
We also compared BFS according to the location of isolated
positive margins, which were categorized as apical, BN or pos-
terolateral using the Kaplan–Meier method. Additionally, we
analyzed the prognostic implication of þBN compared with
–BN, including analysis of whether patients with EPE or SV
involvement had worse BFS when they had a þBN. All stat-
istical analyses were performed using SPSS (version 15.0).
RESULTS
The medical records of a total of 368 patients were reviewed;
132 patients underwent open retropubic RP and 236 patients
underwent robot-assisted RP. The mean+ SD follow-up in
men without BCR was 24.7+ 15.3 months (median 23). A
total of 54 men (21.2%) experienced BCR. The clinical and
pathologic features of patients are presented in Table 1. For
29 patients with pT2 disease, the distributions of positive
margins were apex only (n ¼ 20), BN only (4), posterolateral
only (n ¼ 3) and BN plus apex (n ¼ 2). Table 2 shows the
pathologic features of patients with þBN plus other SM(s).
Of the 368 men in this study, a þBN (which means ‘posi-
tive BN margin’, not the case with microscopic BN invasion
with negative SM) was noted in 50 (13.5%). Of the 50
patients with a þBN, 8 had SVþ so they were included in
the SVþ group, 22 had at least one other positive margin,
leaving 20 men with an isolated þBN (a þBN without
other SMs or SVþ).
Table 1. Clinical and pathologic features of patients undergoing radical
prostatectomy
Mean (SD)
Age 63.5 (6.7)
PSA (ng/ml) 11.1 (11.9)
n (%)
Clinical stage
T1 87 (23.6)
T2/3 281 (76.4)
Pathologic Gleason score
2–6 128 (34.8)
7 182 (49.5)
8–10 58 (15.7)
Surgical margins
pT2 (n ¼ 143) 29 (20.2)
pT3 (n ¼ 225) 90 (40.0)
Pathological stage
OC (EPE2, SV2) 143 (38.9)
EPE (SV2) 200 (54.3)
SV (EPEþ/2) 25 (6.8)
SD, standard deviation; PSA, prostate-speciﬁc antigen; OC, organ conﬁned;
EPE, extraprostatic extension; SV, seminal vesicle.
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The 3-year BFS for men with OC (EPE2, SV2) disease,
EPE (SV2) and SV invasion was 88.9, 74.8 and 18.8%, re-
spectively. For patients with an isolated þBN and þBN
with other þSM, the 3-year BFS was 51.2 and 19.4%,
respectively (Fig. 1). Of note, we observed that the BFS of
men with an isolated þBN was signiﬁcantly higher than that
of men with SV involvement (P ¼ 0.017). Men with a þBN
with other þSM had a risk of recurrence that was most
similar to that of men with SVþ (P ¼ 0.629).
In proportional hazards models predicting BFS, preopera-
tive PSA, pathological Gleason score of 8–10, EPE, SV
invasion and þBN (isolated þBN and þBN with other
þSM) were signiﬁcant predictors of BFS. The multivariate
analysis is detailed in Table 3. Multivariate analysis revealed
that the increased risk of progression associated with an iso-
lated þBN [hazard ratio (HR) 4.34, 95% conﬁdence interval
(CI) 1.40–13.46, P ¼ 0.011] was less than that of SVþ (HR
9.67, 95% CI 3.70–25.25, P, 0.001). As for the þBN with
other þSM, the increased risk of progression (HR 9.32, 95%
CI 3.50–24.82, P, 0.001) was similar to that of men with
SVþ.
When comparing the 3-year BFS according to the location
of isolated þSM, we found no signiﬁcant differences in BFS
among the three (apical, posterolateral and BN) SMþ
groups (P ¼ 0.114). As for the prognostic implication of
þBN compared with –BN, the þBN group had signiﬁcantly
higher incidence of adverse pathologic features (Table 4).
When we compared BFS according to BN margin status
(BNþ vs BN2), BFS of men with þBN was signiﬁcantly
lower than that of men with BN2 (P, 0.0001, Fig. 2).
Patients with EPE or SV invasion revealed a lower BFS
when they had a þBN than when they did not (34.3 vs
79.3% at 3 years, P, 0.001 and 10.0 vs 37.5% at 3 years,
P ¼ 0.21, respectively).
DISCUSSION
In contemporary series, the prevalence of BN involvement
after RP is 2.8–8.7% (8–10). The 1992, 1997 and 2002
AJCC TNM classiﬁcation systems (3–5) classiﬁed Pca with
Table 2. Pathologic features of patients with positive bladder neck margin
plus other surgical margin(s)
SM status BNþ apex
(n ¼ 12)
BNþ
posterolateral
(n ¼ 12)
BNþ
apex þ posterolateral
(n ¼ 4)
PSA [mean (SD)] 19.1 (6.7) 30.6 (18.3) 26.5 (16.4)
Pathologic T stage [n (%)]
pT2 3 (25) 1 (8.3) 1 (25)
pT3 9 (75) 11 (91.7) 3 (75)
Pathologic GS [n (%)]
6 1 (8.3) 0 (0) 1 (25)
7 3 (25) 6 (50) 2 (50)
8–10 8 (66.7) 6 (50) 1 (25)
SM, surgical margin; BN, bladder neck; GS, Gleason score.
Figure 1. Kaplan–Meier curves of biochemical recurrence-free survival
according to pathological groupings. OC, organ conﬁned; EPE, extrapro-
static extension; BN, bladder neck; SM, surgical margin; SV, seminal
vesicle; BCR, biochemical recurrence.
Table 3. Multivariate Cox proportional hazards regression analysis of
factors predicting time to biochemical recurrence in men undergoing radical
prostatectomy
HR (95% CI) P value
PSA (ng/ml) 1.025 (1.008–1.042) 0.004
Pathologic Gleason score
2–6 Reference
7 1.202 (0.599–2.410) 0.605
8–10 2.603 (1.213–5.584) 0.014
Tumor volume
V1 (,1 cm3) Reference
V2a (1–5 cm3) 1.148 (0.369–3.892) 0.750
V2b (.5 cm3) 2.410 (0.688–7.860) 0.198
Pathological grouping
OC Reference
EPE 2.094 (1.190–4.015) 0.048
BN (isolated) 4.341 (1.400–13.461) 0.011
BN (plus other SM) 9.322 (3.501–24.823) ,0.001
SV 9.671 (3.704–25.250) ,0.001
HR, hazard ratio; CI, conﬁdence interval.
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BN involvement within a uniﬁed pT4 category based on the
extension of cancer into an adjacent organ. In the past, a des-
ignation of pT4 was clearly justiﬁed because most þSMs at
the BN consisted of gross invasion of the bladder. Recently,
however, the 7th edition of the AJCC TNM system (2010
AJCC) (6) changed the staging of Pca from its 2002 version
and now includes microscopic BN invasion in the pT3a cat-
egory. The classiﬁcation changed because a þBN is more
commonly noted as a microscopic focus on histopathological
analysis in the current era of PSA screening and earlier Pca
diagnosis. We aimed to investigate the validity of this
change in Asian populations. To our knowledge, this is the
ﬁrst report regarding this issue in the Asian urologic ﬁeld.
As is well known, multiple recent studies (8–14) demon-
strated that the risk of biochemical progression associated
with a þBN is more consistent with pT3 than with pT4.
For instance, Yossepowitch et al. (13) expressed the need for
downstaging of BN involvement in the 1997 TNM staging
system, reporting that BN involvement in RP surgical speci-
mens carried a lower risk of progression than SV invasion.
Buschemeyer et al. (14) reported that a positive BN margin
was associated with a risk of progression similar to that of
SV invasion (T3b disease) when it was concomitant with
other positive margins. They also demonstrated that the risk
of recurrence for an isolated þBN might be closest to that
of a pT3a lesion. Consistent with previous reports, our
results also showed that the risk of recurrence of a þBN
(both isolated þBN and þBN associated with other þSMs)
was no worse than that of SVþ (pT3b).
Despite the apparent consensus that þBNs do not warrant
a pT4 designation, the prognostic signiﬁcance of a þBN
relative to other þSMs is still inconclusive (8,15–19). For
instance, Obek et al. (8) conducted a site-speciﬁc pathologic
analysis of þSMs and reported that a þBN was the most
signiﬁcant adverse prognostic indicator and that it had three
times the risk of BCR of an apical SMþ. However, a 3-year
follow-up study with more patients at the same institution
revealed that BCR was not dictated by the speciﬁc location
of the þSM (17). Similarly, others (9,13,20) found that a
þBN was not associated with any greater risk of recurrence
than other þSMs. Also in the current study, we found no
signiﬁcant differences in BFS among the three (apical,
posterolateral and BN) þSM groups (P ¼ 0.114).
As for another aspect regarding the prognostic implication
of þBN, numerous prior studies (8–10,12,14) demonstrated
that þBN accompanies other adverse pathological features
such as higher rates of EPE, SV involvement and þSMs,
a higher PSA and a greater pathological Gleason sum.
Our series also corroborates prior evidence: 50 patients who
had þBN in our study showed higher rates of ECE, other
þSM, SV invasion and worse BFR when compared with the
2BN group (Table 4, Fig. 2). Additionally, when we ana-
lyzed whether men with EPE or SV involvement had worse
BFS when they had a þBN, both EPE and SV involvement
group with þBN showed worse BFS than those without
þBN (34.3 vs 79.3% at 3 years, P, 0.001 and 10.0 vs
37.5% at 3 years, P ¼ 0.21, respectively). This ﬁnding was
similar to that of a previous report (21).
Finally, we observed that men with isolated þBN (and
SV2) showed much higher BFS than those with þBN plus
other þSM (and SV2) (Fig. 1, Table 3). Regarding this
result, we fully agree with Buschemeyer et al. (14) who sug-
gested a hypothesis that an isolated þBN may be analogous
to capsular incision due to a less than ideal operation,
Table 4. Patient characteristics by the presence or absence of BN invasion
Characteristics Bladder neck invasion P value
Absent Present
No. of patients 318 50 –
Mean age (SD) 63.9 (6.4) 62.1 (8.1) 0.306
Mean BMI (SD) 24.2 (2.3) 23.2 (1.9) 0.177
Mean PSA (SD) 8.6 (6.0) 26.6 (22.9) ,0.0001
No. of clinical stage (%)
T1 76 (23.9) 12 (24.0) 0.987a
T2/3 242 (76.1) 38 (76.0)
No. of pathologic Gleason score (%)
2–6 118 (37.1) 10 (20.0) ,0.001a
7 159 (50.0) 24 (48.0)
8–10 41 (12.9) 16 (32.0)
No. of ECE (%) 186 (58.5) 38 (76.0) 0.018a
No. of positive SMs (%) 98 (30.8) 21 (42.0) 0.116a
No. of SVþ (%) 13 (4.1) 12 (24.0) ,0.0001a
BMI, body mass index.
aChi-square test.
Figure 2. Kaplan–Meier curves of BCR-free survival according to BN
margin status. BN, bladder neck; BCR, biochemical recurrence.
Jpn J Clin Oncol 2013;43(2) 187
 at Y
O
N
SEI U
N
IV
ERSITY
 M
ED
ICA
L LIBRA
RY
 on M
ay 20, 2014
http://jjco.oxfordjournals.org/
D
ow
nloaded from
 
whereas þBN plus other þSM may be due to advanced
disease and aggressive tumor biology.
The present study had several limitations. First, this study
was conducted retrospectively at a single institution, and the
study sample was relatively small. Second, we did not
include information on pelvic lymph node dissection (due to
small number) and Pca-speciﬁc survival data. Third, patho-
logical determination of þBN was not done under central
review and a positive SM at the BN proper and at the base
of the prostate may have been investigated together, although
we think that this limitation does not diminish the signiﬁcant
message of this article. We believe that our study presents
important preliminary results to assess the validity of the
recent change in PCa staging in the AJCC 2010 staging
system, in the Asian urologic ﬁeld.
In conclusion, the present study demonstrates that it is rea-
sonable to classify Pca with BN invasion (the 6th AJCC
edition pT4 category) into the 7th edition pT3 category.
Further large-scale, multi-center studies are needed to
conﬁrm our ﬁndings with increased statistical power.
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